Is there any relationship between Toll-like receptor 3 c.1377C/T and −7C/A polymorphisms and susceptibility to Crimean Congo hemorrhagic fever?

Journal of Medical Virology

Volumn 88, Issue 10, 2016, Pages 1690-1696

  Engin, Aynur ^a   Arslan, Serdal ^a   Özbilüm, Nil ^a   Bakir, Mehmet ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Crimean Congo hemorrhagic fever; polymorphism; toll like receptor 3

Indexed keywords

INTERFERON; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; DISEASE SEVERITY; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL VARIATION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL GENETICS;

EID: 84979955464     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24519     Document Type: Article

References (32)

1. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783–801.
2. Alagarasu K, Bachal RV, Memane RS, Shah PS, Cecilia D. 2015. Polymorphisms in RNA sensing toll like receptor genes and its association with clinical outcomes of dengue virus infection. Immunobiology 220:164–168.
3. Al-Qahtani A, Al-Ahdal M, Abdo A, Sanai F, Al-Anazi M, Khalaf N, Viswan NA, Al-Ashgar H, Al-Humaidan H, Al-Suwayeh R, Hussain Z, Alarifi S, Al-Okail M, Almajhdi FN. 2012. Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients. J Med Virol 84:1353–1359.
4. Arslan S, Engin A, Özbilüm N, Bakır M. 2015. Toll-like receptor 7 Gln11Leu, c.4-151A/G, and +1817G/T polymorphisms in Crimean Congo hemorrhagic fever. J Med Virol 87:1090–1095.
5. Ayithan N, Bradfute SB, Anthony SM, Stuthman KS, Dye JM, Bavari S, Bray M, Ozato K. 2014. Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways. J Interferon Cytokine Res 34:79–89.
6. Barkhash AV, Voevoda MI, Romaschenko AG. 2013. Association of single nucleotide polymorphism rs3775291 in the coding region of the TLR3 gene with predisposition to tick-borne encephalitis in a Russian population. Antiviral Res 99:136–138.
7. Barton GM. 2007. Viral recognition by Toll-like receptors. Semin Immunol 19:33–40.
8. Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M. 2013. Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res 100:159–189.
9. Biyani S, Garg RK, Jain A, Malhotra HS, Kumar R, Prakash S, Verma R, Sharma PK. 2015. Toll-like receptor-3 gene polymorphism in patients with Japanese encephalitis. J Neuroimmunol 286:71–76.
10. Broering R, Wu J, Meng Z, Hilgard P, Lu M, Trippler M, Szczeponek A, Gerken G, Schlaak JF. 2008. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J Hepatol 48:914–922.
11. Cheng PL, Eng HL, Chou MH, You HL, Lin TM. 2007. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Transl Res 150:311–318.
12. Engin A, Arslan S, Kizildag S, Oztürk H, Elaldi N, Dökmetas I, Bakir M. 2010. Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever. Microbes Infect 12:1071–1078.
13. Ergonul O. 2012. Crimean-Congo hemorrhagic fever virus: New outbreaks, new discoveries. Curr Opin Virol 2:215–220.
14. Etem EO, Elyas H, Ozgocmen S, Yıldırım A, Godekmerdan A. 2011. The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. Rheumatol Int 31:1369–1374.
15. Frazão JB, Errante PR, Condino-Neto A. 2013. Toll-like receptors’ pathway disturbances are associated with increased susceptibility to infections in humans. Arch Immunol Ther Exp (Warsz) 61:427–443.
16. Gao H, Leaver SK, Burke-Gaffney A, Finney SJ. 2008. Severe sepsis and Toll-like receptors. Semin Immunopathol 30:29–40.
17. Gao Y, Guo J, Zhang F, Guo Z, Zhang LR, Wang T, Wang B, Feng SY, Wang SP. 2015. Evaluation of neonatal Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in HBV intrauterine transmission susceptibility. Epidemiol Infect 143:1868–1875.
18. Gowen BB, Hoopes JD, Wong MH, Jung KH, Isakson KC, Alexopoulou L, Flavell RA, Sidwell RW. 2006. TLR3 deletion limits mortality and disease severity due to Phlebovirus infection. J Immunol 177:6301–6307.
19. Huang X, Li H, Wang J, Huang C, Lu Y, Qin X, Li S. 2015. Genetic polymorphisms in Toll-like receptor 3 gene are associated with the risk of hepatitis B virus-related liver diseases in a Chinese population. Gene 569:218–224.
20. Huik K, Avi R, Pauskar M, Kallas E, Jõgeda EL, Karki T, Marsh K, Des Jarlais D, Uusküla A, Lutsar I. 2013. Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users. Infect Genet Evol 20:78–82.
21. Ince Y, Yasa C, Metin M, Sonmez M, Meram E, Benkli B, Ergonul O. 2014. Crimean-Congo hemorrhagic fever infections reported by ProMED. Int J Infect Dis 26:44–46.
22. Ishizaki Y, Takemoto M, Kira R, Kusuhara K, Torisu H, Sakai Y, Sanefuji M, Yukaya N, Hara T. 2008. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis. J Neurovirol 14:486–491.
23. Mandal RK, George GP, Mittal RD. 2012. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population. Mol Biol Rep 39:7263–7269.
24. Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Lal P, Mittal RD. 2011. Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility. Mol Biol Rep 38:4715–4721.
25. Ranjith-Kumar CT, Miller W, Sun J, Xiong J, Santos J, Yarbrough I, Lamb RJ, Mills J, Duffy KE, Hoose S, Cunningham M, Holzenburg A, Mbow ML, Sarisky RT, Kao CC. 2007. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J Biol Chem 282:17696–17705.
26. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. 1989. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 11:S794–S800.
27. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu Rev Immunol 21:335–376.
28. Tapping RI, Omueti KO, Johnson CM. 2007. Genetic polymorphisms within the human Toll-like receptor 2 subfamily. Biochem Soc Trans 35:1445–1448.
29. Tapping RI. 2009. Innate immune sensing and activation of cell surface Toll-like receptors. Semin Immunol 21:175–184.
30. Terwilliger JD, Ott J. 1993. A novel polylocus method for linkage analysis using the lodscore or affected sib-pair method. Genet Epidemiol 10:477–482.
31. Tsai YT, Chang SY, Lee CN, Kao CL. 2009. Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol 11:604–615.
32. Wu J, Lu M, Meng Z, Trippler M, Broering R, Szczeponek A, Krux F, Dittmer U, Roggendorf M, Gerken G, Schlaak JF. 2007. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46:1769–1778.